Moderna, Inc. is a Cambridge, Massachusetts-based biotechnology company that is focused on drug discovery and drug development based on messenger RNA (mRNA). The company creates synthetic mRNA that can be injected into patients to help them create their own therapies.
Click to see more
Moderna Inc. Details
Operating Status:Active
Business TypePublic
HeadquartersCambridge, Massachusetts, United States
In addition to noting that Moderna will lead the RSV vaccine market, Cowen also referred to major opinion leaders’ belief in the pharmaceutical company competing in a “three-player vaccine market”.
Except for its recent jump, Moderna stock has been at the lows. The remarkable Q1 2022 performance may give Moderna a boost and help its stock to rebound.
